4,7-Dichloro-2-hydrazino-1,3-benzothiazole, 95.0%, 250mg

Methyl 4-(dimethylphosphoryl)thiophene-2-carboxylate, 98%, 50mg

(S)-Tetrahydrofurfurylamine, 95.0%, 5g

(4-(1-Methyl-1H-pyrazol-3-yl)phenyl)methanol, 95.0%, 250mg

2-(2-Bromo-4-methoxyphenoxy)acetonitrile, 98%, 1g

6,7-Dihydro-5H-[1,2,4]triazolo[3,4-b][1,3]thiazin-3-ylamine, 95.0%, 250mg

(R)-tert-Butyl (3-oxocyclopentyl)carbamate, 95.0%, 5g

2-(Aminomethyl)-3-fluorophenol hydrochloride, 250mg

(3R,4R)-4-fluoro-3-pyrrolidinol hydrochloride, 95.0%, 25g

Immobilon-P, Porengröße 0,45 µm, Rolle, 375 x 28 cm, PVDF-Membran, 1 Rolle(n)

2-(4-Isopropyl-piperazin-1-yl)-ethylamine, 95.0%, 1g

N4,N4,N4',N4'-Tetramethyl-[2,2'-bipyridine]-4,4'-diamine, 97%, 1g

beta-D-Glucopyranose 1-Phosphate Disodium Salt>98.0%(HPLC)100mg